FY2024
Effective from
- Added
Wasting disease (syndrome) due to underlying condition
Billable diagnosis code
CDC/NCHS · FY2024underlying condition
codes for associated conditions
histiocytosis X (chronic) (C96.6)
Ehlers-Danlos syndromes (Q79.6-)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2023-10-01
Latest recorded change · FY2024
Effective from
Wasting disease (syndrome) due to underlying condition
Billable diagnosis code
CDC/NCHS · FY2024| All editions | Effective from | Code history |
|---|---|---|
| FY2024 | 2023-10-01 | Added |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Cachexia due to underlying condition
underlying condition
histiocytosis X (chronic) (C96.6)
codes for associated conditions
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Ehlers-Danlos syndromes (Q79.6-)
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: R64
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E88.0 | Disorders of plasma-protein metabolism, not elsewhere classified | Category · further specificity required |
| E88.1 | Lipodystrophy, not elsewhere classified | Category · further specificity required |
| E88.2 | Lipomatosis, not elsewhere classified | Billable / specific |
| E88.3 | Tumor lysis syndrome | Billable / specific |
| E88.4 | Mitochondrial metabolism disorders | Category · further specificity required |
| E88.8 | Other specified metabolic disorders | Category · further specificity required |
| E88.9 | Metabolic disorder, unspecified | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗
Use additional code · code, if applicable, for associated cachexia (E88.A)
Use additional code · code, if applicable, for associated cachexia (E88.A)
Use additional code · associated cachexia (E88.A)
Excludes 1 · cachexia due to underlying condition (E88.A)
Use additional code · code, if applicable, for associated cachexia (E88.A)